23andme CEO Anne Wojcicki moves to take company private

After a tumultuous experience on the public markets, 23andMe CEO Anne Wojcicki is moving to take the company private.

Wojcicki disclosed her plans in a filing with the Securities and Exchange Commission late Wednesday, saying that she intends to seek out potential partners and financiers to help. Wojcicki currently holds 49.99% of the voting power in the company, according to the Wall Street Journal, which first reported on the plan.

The company was once an industry darling, its star rising — and then falling — with the consumer genetics boom of the 2010s. For many years, the company’s main business has been selling at-home testing genetic kits, but Wojcicki has pushed the company to use the genetic insights gleaned from millions of consumer samples to create new medicines.